Latest Posts

Yosi Yahoudai Listed as Rising Star in the 2017 Super Lawyers Magazine

Javaheri & Yahoudai PC

Los Angeles, CA (Law Firm Newswire) July 19, 2017 – Yosi Yahoudai, founder and managing partner of J&Y, a well-known personal injury practice with 21 offices throughout California, was recently listed as a Rising Star in the 2017 Super Lawyers Magazine.

Super Lawyers rates exceptional lawyers from more than 70 practice areas according to several criteria, including peer recognition and professional achievement. In order to attain “Rising Star” status, an attorney must pass through the same multi-phase selection process used to select “Super Lawyers.” The only difference is that, in order to be eligible for inclusion in the Rising Star category, the candidate in question must be either 40 years old or younger or have been in practice for 10 years or less.

Mr. Yahoudai’s achievement is an outstanding one since only 2.5 percent of attorneys in the state are designated “Rising Stars” (5 percent are designated “Super Lawyers”). His recent honor demonstrates that he is one of very few lawyers in the state of California who received the highest point levels during the three phases of the selection process: nomination, research, and peer review.

In recognition of his recent distinction, Mr. Yahoudai has been honored by his alma mater, Southwestern Law School, as someone who “upholds the long-established tradition of excellence and service to the legal profession and the community,” and who “also establishes a new model to inspire and guide today’s students.”

Contact:
Javaheri & Yahoudai PC
Email: [email protected]
Phone: Toll free (877) 735-7035.

See other news sources publishing this article. BETA | Tags: ,

Florida Mesothelioma Victims Center Now Suggests the Nation’s Top Three Law Firms When It Comes to A Navy Veteran with Mesothelioma in Florida Getting the Best Possible Compensation

The fulltime mesothelioma attorneys we have listed are considered to be among the leading mesothelioma attorneys in the nation for Navy Veterans with this rare cancer-call them”

— Florida Mesothelioma Victims Center

NEW YORK, NEW YORK, USA, July 17, 2017 /EINPresswire.com/ — The Florida Mesothelioma Victims Center says, “There might be car accident attorneys who proclaim they also do mesothelioma-but doing a mesothelioma compensation claim successfully for a Navy Veteran who has been diagnosed with this rare cancer requires more than a license to practice law. A Navy Veteran in Florida who has recently been diagnosed with mesothelioma deserves to have the very best legal representation in the nation because their financial compensation depends on it-as we would like to discuss anytime at 800-714-0303.” http://Florida.MesotheliomaVictimsCenter.Com

In all likelihood-a mesothelioma compensation claim involving a US Navy Veteran in Florida will involve a US Navy Base or US Navy Shipyard not in Florida. It is for this reason we place such a huge premium on making certain a Navy Veteran in Florida has on the spot access to the nation’s top mesothelioma attorneys whose law firms are the gold standard for mesothelioma compensation settlements. We know the news of a mesothelioma diagnosis can be devastating for an individual or their family. What we do not want to see happen is a diagnosed Navy Veteran in Florida or their family to act impulsively when it comes to hiring a lawyer or law firm as they would like to explain in detail at 800-714-0303. http://Florida.MesotheliomaVictimsCenter.Com

Note from the Florida Mesothelioma Victims Center, “If you have been diagnosed with mesothelioma and your asbestos exposure occurred while you were serving in the US Navy or a US Navy Shipyard the the fulltime mesothelioma attorneys we have listed are considered to be among the leading mesothelioma attorneys in the nation when it comes to mesothelioma compensation. We are certain they will personally want to talk to you directly if you have this rare form of cancer because of asbestos exposure on a US Navy ship, or while your ship was at a US Navy Shipyard.” http://Florida.MesotheliomaVictimsCenter.Com

Vital Tip related to a US Navy Veteran hiring some of the nation’s top mesothelioma attorneys from the Florida Mesothelioma Victims Center: The Center’s number one tip for a Navy Veteran in Florida would be contacting one of the three attorneys listed.

* Steven Kazan-Oakland, California-877-995-6372
* Joseph Belluck-New York-877-637-6843
* Peter Kraus-Dallas/Los Angeles-800-226-9880

The Florida Mesothelioma Victims Center wants to emphasize there is a statewide initiative available to a diagnosed victim anywhere in Florida including communities such as Miami, Jacksonville, Tampa, Saint Petersburg, Orlando, Hialeah, Fort Lauderdale, Tallahassee, Port Saint Lucie, or Cape Coral. http://Florida.MesotheliomaVictimsCenter.Com

Aside from their focus on the best possible compensation the Center is also very passionate about treatment options for mesothelioma. For the best possible mesothelioma treatment options in Florida the Florida Mesothelioma Victims Center strongly recommends the following heath care facility with the offer to help a diagnosed victim, or their family get to the right physicians at this hospital: The H. Lee Moffitt Cancer Center in Tampa, Florida: http://moffitt.org/

High-risk work groups for exposure to asbestos now living in Florida include US Navy Veterans, power plant workers, shipyard workers, oil refinery workers, steel mill workers, miners, manufacturing workers, plumbers, electricians, auto mechanics, machinists or construction workers. Typically, the exposure to asbestos occurred in the 1950’s, 1960’s, 1970’s, or 1980’s. In most instances, the diagnosed person was not exposed to asbestos in Florida but rather in the Northeast or Midwest.

The Florida Mesothelioma Victims Center says, “If you have been diagnosed with mesothelioma and you live in Florida please call us at 800-714-0303, and compare the qualifications of who we consider to be the nation’s most skilled mesothelioma attorneys to any other lawyer, or law firm.”
http://Florida.MesotheliomaVictimsCenter.Com

For more information about mesothelioma please refer to the National Institutes of Health’s web site related to this rare form of cancer: http://www.nlm.nih.gov/medlineplus/mesothelioma.html

Michael Thomas
Florida Mesothelioma Victims Center
800-714-0303
email us here

New York-Based Law Firm Provides Clarity and Power for Parents of Children With Cerebral Palsy — The Fitzgerald Law Firm

YONKERS, NY–(Marketwired – July 17, 2017) – Even though an estimated 760,000 children and adults in the U.S. have well-developed symptoms of cerebral palsy (CP), the complexities of the condition can generate confusion about it among the general public.

/EINPresswire.com/ — To stimulate clarity and understanding about CP, attorneys with The Fitzgerald Law Firm have developed an online information page that utilizes laymen’s terms to illustrate the specifics of the condition.

The CP information page can be found at http://bit.ly/cerebral-palsy-info.

“More than 10,000 babies are born in the U.S. each year with various symptoms of CP,” said one Fitzgerald attorney. “Triggered by a disruption during the development of the brain, usually before the child is born or during the delivery process, CP can rob a child of their ability of movement, coordination and muscle tone.”

Not surprisingly, CP is among the most common forms of birth injuries. In addition to certain situations (fetal stroke, abnormal development of the brain, lack of oxygen and others) that can lead to the development of CP, it can also be caused by certain forms of medical malpractice, including:

  • Complications with the umbilical cord;
  • Mismanagement of mother’s and infant’s vital signs;
  • Delayed delivery; or
  • Failure to perform a cesarean section delivery.

“Information is power, and this page provides parents of children with CP plenty of power as they decide whether or not to pursue legal action to recover proper compensation necessary to provide care for their loved one,” said the Fitzgerald attorney.

About The Fitzgerald Law Firm: The Fitzgerald Law Firm, is a medical malpractice law firm in New York focused in protecting the rights of their clients who have suffered from medical malpractice injuries and hospital negligence. For more than 40 years, the Fitzgerald has successfully represented hundreds of cases throughout New York and across the country.

The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Roche Holding AG Shareholders and a Lead Plaintiff Deadline of August 7, 2017 (RHHBY)

NEW YORK, July 17, 2017 (GLOBE NEWSWIRE) — The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Roche Holding AG (OTCMKTS:RHHBY) who purchased shares between March 2, 2017 and June 5, 2017. The action, which was filed in the United States District Court for the District of New Jersey, alleges that the Company violated federal securities laws.

In particular, the complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that (1) the combination of Perjeta and Herceptin is only marginally more effective than Herceptin alone in preventing breast cancer; and (2) as a result, Defendants’ statements about Roche Holding AG’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Shareholders have until August 7, 2017 to petition the court for lead plaintiff status. Your ability to share in any recovery does not require that you serve as lead plaintiff. You may choose to be an absent class member.

If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit http://www.kleinstocklaw.com/pslra-sa/roche-holding-ag?wire=3.

Joseph Klein, Esq. is an experienced attorney and has also practiced as a Certified Public Accountant. Mr. Klein represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
                    Joseph Klein, Esq.
                    Empire State Building
                    350 Fifth Avenue
                    59th Floor
                    New York, NY 10118
                    Telephone: (212) 616-4899
                    Fax: (347) 558-9665
                    www.kleinstocklaw.com

/EIN News/ — Primary Logo

The Klein Law Firm Notifies Investors of a Class Action Filed on Behalf of FleetCor Technologies, Inc. Shareholders and a Lead Plaintiff Deadline of August 14, 2017 (FLT)

NEW YORK, July 17, 2017 (GLOBE NEWSWIRE) — The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of FleetCor Technologies, Inc. (NYSE:FLT) who purchased shares between February 5, 2016 and May 2, 2017. The action, which was filed in the United States District Court for the District of Georgia, alleges that the Company violated federal securities laws.

In particular, the complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that (1) the Company misled investors regarding the sources of and reasons for its earnings and growth; (2) the Company falsely stated that it clearly discloses its fees to customers and that its business is focused on helping employers control spending and save money. On March 1, 2017, Capitol Forum published an article describing how FleetCor’s business model relies on overcharging customers and padding fee income through late fees even when customers pay on time. Then on April 4, 2017, Citron issued a report accusing FleetCor of being a “predatory company by design, whose core strategy is to methodically rip off its customers…” Then on April 27, 2017, Citron released another report explaining that FleetCor had allegedly developed a scheme to categorize its customers based on the level of improper fees the Company could charge without customer complaint.

Shareholders have until August 14, 2017 to petition the court for lead plaintiff status. Your ability to share in any recovery does not require that you serve as lead plaintiff. You may choose to be an absent class member.

If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit http://www.kleinstocklaw.com/pslra-sb/fleetcor-technologies-inc?wire=3.

Joseph Klein, Esq. is an experienced attorney and has also practiced as a Certified Public Accountant. Mr. Klein represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
                    Joseph Klein, Esq.
                    Empire State Building
                    350 Fifth Avenue
                    59th Floor
                    New York, NY 10118
                    Telephone: (212) 616-4899
                    Fax: (347) 558-9665
                    www.kleinstocklaw.com

/EIN News/ — Primary Logo

Rosen Law Firm Reminds Mazor Robotics Ltd. Investors of Important Deadline in Class Action – MZOR

NEW YORK, July 17, 2017 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Mazor Corporation (NASDAQ:MZOR) from November 8, 2016 through June 8, 2017, both dates inclusive (the “Class Period”) of the important August 8, 2017 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Mazor investors under the federal securities laws.

To join the Mazor class action, go to the firm’s website at http://www.rosenlegal.com/cases-1144.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll free at 866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for more information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, throughout the Class Period defendants issued false and misleading statements to investors and/or failed to disclose that: (1) Mazor was engaged in conduct that subjected it to ISA investigation; (2) as such, Mazor was exposed to potential liability; and (3) as a result, defendants’ statements about Mazor’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 8, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to the firm’s website at http://www.rosenlegal.com/cases-1144.html for more information. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or kchan@rosenlegal.com.

Follow us on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Since 2014, Rosen Law Firm has been ranked #2 in the nation by Institutional Shareholder Services for the number of securities class action settlements annually obtained for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.

/EIN News/ —

Contact Information:
                    Laurence Rosen, Esq.
                    Phillip Kim, Esq.
                    Kevin Chan, Esq.
                    The Rosen Law Firm, P.A.
                    275 Madison Avenue, 34th Floor
                    New York, NY  10016
                    Tel: (212) 686-1060
                    Toll Free: (866) 767-3653
                    Fax: (212) 202-3827
                    lrosen@rosenlegal.com
                    pkim@rosenlegal.com
                    kchan@rosenlegal.com
                    www.rosenlegal.com

The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Albany Molecular Research, Inc. – AMRI

BROOKLYN, N.Y., July 17, 2017 (GLOBE NEWSWIRE) — The Rosen Law Firm, P.A. announces that the United States District Court for the Eastern District of New York has approved the following announcement of a proposed class action settlement that would benefit purchasers of common stock of Albany Molecular Research, Inc. (NASDAQ:AMRI):

SUMMARY NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF CLASS ACTION AND FAIRNESS HEARING

/EIN News/ — TO: ALL PURCHASERS OF COMMON STOCK OF ALBANY MOLECULAR RESEARCH, INC. (“AMRI”) DURING THE PERIOD FROM AUGUST 5, 2014 THROUGH NOVEMBER 5, 2014, INCLUSIVE.

YOU ARE HEREBY NOTIFIED, pursuant to an Order of the United States District Court for the Eastern District of New York, that a hearing will be held before the Honorable Frederic Block, United States District Judge, on October 12, 2017 at 12:00 p.m. in Courtroom 1040 of the U.S. District Court for the Eastern District of New York, 225 Cadman Plaza East, Brooklyn, New York 11201, for the purpose of determining, among other things, (i) whether the proposed Settlement of this Action for $2,868,000 is fair, reasonable, and adequate and should be approved; (ii) whether this Action should be dismissed with prejudice as against the Defendants as set forth in the Amended Stipulation of Settlement dated as of June 23, 2017; (iii) whether the Plan of Allocation of the Net Settlement Fund is fair and reasonable and should be approved; and (iv) the reasonableness of an application of Lead Counsel for the payment of attorneys’ fees and expenses, incurred in connection with this Action. Lead Counsel intends to seek attorneys’ fees and reimbursement of expenses not to exceed $956,000 (33 1/3% of the Settlement Amount) and awards to Lead Plaintiffs of no greater than $12,000 ($6,000 each).

The Court has reserved the right to reschedule the hearing from time to time without further notice.

If, between August 5, 2014 and November 5, 2014, inclusive, (the “Settlement Class Period”) you purchased AMRI common stock, your rights may be affected by this Action and the settlement thereof. If you have not received the detailed Notice of Pendency and Proposed Settlement of Class Action and Fairness Hearing (the “Notice”) and Proof of Claim and Release form, you may obtain them free of charge at www.strategicclaims.net; by sending an e-mail to info@strategicclaims.net; by calling the Claims Administrator toll-free at 866-274-4004; or by writing to the Claims Administrator at: Albany Molecular Research, Inc. Litigation, c/o Strategic Claims Services, P.O. Box 230, 600 N. Jackson St., Ste. 3, Media, PA 19063. You may also contact Lead Counsel directly: Laurence Rosen, Esq. or Phillip Kim, Esq., The Rosen Firm, P.A., 275 Madison Avenue, 34th Floor, New York, New York 10016, (212) 686-1060.

If you are a member of the Settlement Class and wish to share in the Settlement money, you must submit a Proof of Claim and Release form postmarked no later than September 21, 2017 to the Claims Administrator establishing that you are entitled to recovery.  As further described in the Notice, you will be bound by any judgment entered in the Action, regardless of whether you submit a Proof of Claim and Release form, unless you exclude yourself from the Settlement Class, in accordance with the procedures set forth in the Notice, postmarked no later than September 21, 2017 to the Claims Administrator. Any objections to the Settlement, Plan of Allocation or attorneys’ fees and expenses must be filed and served, in accordance with the procedures set forth in the Notice, received no later than September 21, 2017 to each of the following:

Clerk of the Court
U.S. District Court
Eastern District of New York
225 Cadman Plaza East
Brooklyn, NY 11201
Laurence M. Rosen, Esq.
Phillip Kim, Esq.
THE ROSEN LAW FIRM, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016

 
Lead Counsel

Deborah S. Birnbach, Esq.
Goodwin Procter LLP
100 Northern Avenue
Boston, MA  02210

Counsel for Defendants 

If you have any questions about the Settlement, you may call or write to Lead Counsel:

Laurence M. Rosen, Esq.
Phillip Kim, Esq.
THE ROSEN LAW FIRM, P.A.
275 Madison Avenue, 34th Floor
New York, New York 10016
Tel.:  212-686-1060
Fax:  212-202-3827

PLEASE DO NOT CONTACT THE COURT OR
THE CLERK’S OFFICE ABOUT THIS NOTICE.

Dated:  June 23, 2017

BY ORDER OF THE U.S. DISTRICT COURT
FOR THE EASTERN DISTRICT OF NEW YORK 

Omissions and incorrect interpretations in IRD trusts taxation statement, says NZLS

An Inland Revenue Interpretation Statement on income taxation of trusts has some key omissions and also incorrectly interprets the law in some areas, the New Zealand Law Society says.

In a submission on PUB00261: Interpretation Statement: IS XX/XX Taxation of Trusts – Income Tax, the Law Society says the statement does not cover a number of areas, with key omissions including the application of double tax agreements to trusts, and whether beneficiaries become settlors by having a credit current account balance.

“Overall, the Law Society’s view is that, while we understand that this is an Interpretation Statement of the current law as Inland Revenue sees it, it would be beneficial to consider placing the widely acknowledged problems with the current legislation on the work programme to be reviewed and where required, amended,” the submission says.

“In the meantime, the Law Society submits that a purposive interpretation of the current law is required, to ensure that the law does not overreach what Parliament has intended under the current provisions.”

In its comments on the inaccuracies, the Law Society says the statement that foreign-sourced amounts distributed to non-resident beneficiaries are also not subject to tax in New Zealand “unless they are included in a taxable distribution made by a non-complying trust” is incorrect.

The Law Society says this statement is referred to in three other places in the interpretation statement. It says provisions in section BD of the legislation show that certain taxable distributions can be a foreign-sourced amount and will not be taxable where the beneficiary is a non-resident or a transitional resident.

Other incorrect statements can be found in paragraphs [7.14a], [8.32], [10.13], [11.3] and [13.37], the Law Society says, along with a number of other misleading assumptions and statements.

USCIS Publishes List of Terminated EB-5 Regional Centers

Dallas immigration lawyers

Dallas immigration lawyers – Rabinowitz & Rabinowitz, P.C.

Dallas, TX (Law Firm Newswire) July 17, 2017 – U.S. Citizenship and Immigration Services (USCIS) published a list of 116 EB-5 Regional Centers that have had their participation in the Immigrant Investor Program terminated. As of June 5, 2017, there were 859 Regional Centers approved by USCIS.

The EB-5 Immigrant Investor Visa Program provides a path to permanent residence for certain eligible immigrant investors. To be eligible, immigrant investors must invest $1 million or more in a U.S. business that will eventually employ 10 or more American workers, directly or indirectly. The investment threshold is lowered to $500,000 if the immigrant invests in one of several Targeted Employment Areas, which are rural areas or areas with high unemployment. Applicants may invest directly, or they may pool their funds to invest in Regional Centers, which are third-party intermediaries. Regional Centers are entities that have been approved by USCIS to create projects for EB-5 investors.

“When 80+ percent of EB-5 Regional Center petitioners are from the People Republic of China, and there is a multi-year wait for a visa number before such persons are eligible to immigrate to the United States, together with a multi-year wait for USCIS EB-5 case adjudication, it stands to reason that these delays will lower interest levels in the EB-5 program in China,” said Stewart Rabinowitz, a Dallas, Texas and Frisco, Texas immigration attorney with the firm of Rabinowitz & Rabinowitz, P.C. “With lower demand comes increasing regional center inactivity resulting in a shrinking in the number of regional centers.”

The EB-5 program has emerged as an important source of funding for many major development projects, including hotels, restaurants, resorts, casinos, stadiums and multi-use developments. In 2015 and 2016, the Securities and Exchange Commission brought enforcement actions against several EB-5 projects for misusing investors’ funds. The Immigrant Investor Visa Program was renewed on May 5, 2017 by President Trump and is currently extended through September 30, 2017.

By Appointment Only
Three Galleria Tower
13155 Noel Road, Suite 900
Dallas, TX 75240
http://www.rabinowitzrabinowitz.com

See other news sources publishing this article. BETA |